Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 13/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.34 |
| ▸ | TPSD1 | Q9BZJ3 | 1/20 | 0.34 |
| ▸ | TPSG1 | Q9NRR2 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9835706 | 0.90 | TBXAS1 (0.72) | TBXAS1ALDH1A1GAA | |
| SCHEMBL9837013 | 0.84 | TBXAS1 (1.00) | TBXAS1ALDH1A1GAAEGLN3 | |
| Hydrochloric Acid SCHEMBL9837253 | 0.83 | TBXAS1 (0.98) | TBXAS1ALDH1A1GAAEGLN3 | |
| SCHEMBL9835790 | 0.82 | TBXAS1 (0.79) | TBXAS1ALDH1A1GAAKDM4E | |
| SCHEMBL9835990 | 0.81 | TBXAS1 (0.72) | TBXAS1ALDH1A1GAA | |
| SCHEMBL9837142 | 0.73 | TBXAS1 (1.00) | TBXAS1ALDH1A1GAA | |
| Hydrochloric Acid SCHEMBL9836713 | 0.72 | TBXAS1 (0.98) | TBXAS1ALDH1A1GAA | |
| SCHEMBL9836796 | 0.72 | TBXAS1 (0.43) | TBXAS1ALDH1A1 | |
| SCHEMBL9835717 | 0.71 | TBXAS1 (0.44) | TBXAS1 | |
| SCHEMBL9836019 | 0.71 | TBXAS1 (0.72) | TBXAS1ALDH1A1GAAEGLN3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0240107-B1 | THIANAPHTHENE DERIVATIVES, THEIR PRODUCTION AND USE | Sankyo Company Limited (JP) | 1991-08-21 | — | — | EP | claimed |